Diet Drug Acomplia (Rimonabant) Doubles Risk of Depression — European Regulators
Taking diet drug Acomplia (rimonabant) approximately doubles your risk of depression, and the risk may be even higher if you have a past history of depression, according to the European Medicines Agency (EMEA).
“ This doubling of the risk of depression occurs in all types of patients,” the EMEA’s [...]
FDA Approves New Diet Drug, But Not Acomplia or Alli (and Also Not for Humans)
For all those awaiting Food and Drug Administation action on a new diet drug, the on Jan. 5th approved one — but it was not highly anticipated Acomplia (rimonabant) and not Alli (the long-awaited over-the-counter version of Xenical).
In fact, it is not a diet drug [...]
UK Company Plans Trial of Diet Drug With Same Target as Acomplia (Rimonabant)
GW Pharmaceuticals Acomplia (rimonabant) , a U.K. company with an announced goal of being the global leader in prescription cannabinoid medicine, said on Jan. 30 it hopes to soon start a Phase I clinical trial of an experimental diet drug derived from cannabis.
The company said researchers [...]
2d Generic Version of Diet Pill Rimonabant (Acomplia / Zimulti) Launched in India
ond Acomplia (rimonabant) Indian pharmaceutical company, Torrent Pharmaceuticals Ltd., has announced that it also is selling a generic version of the new Sanofi-Aventis diet drug Acomplia (rimonabant) under the name Rimoslim.
The news, which attracted little attention in the West, occurred almost simultaneously with last week’s announcement by Zydus [...]
A year ago at this time, millions of overweight and obese Americans were excitedly awaiting both a new prescription weight-loss drug, rimonabant (Acomplia / Zimulti) , and the first over-the-counter diet drug, Alli (low-dose Xenical), which were expected to be on the U.S. market by summer. [...]
Acomplia (Rimonabant) Shows Promise
UK biopharmaceutical company Vernalis on Sept. 14th announced that a diet drug it is developing similar to Acomplia (rimonabant) , V24343, had produced “striking weight loss” in patients in two small phase I clinical trials, with one patient losing 24 pounds in just over two weeks.
The [...]
Diet Drug Acomplia Sales Dwarfed by Initial Sales of Diet Pill alli
Just how badly sales of diet drug Acomplia (rimonabant) have been set back by Sanofi’s inability to bring it to the U.S. market was dramatically illustrated July 25th when GlaxoSmithKline revealed initial launch results for over-the-counter diet pill alli (low-dose Xenical).
Sales of non-prescription alli totaled a [...]
Most Significant ‘Wait Loss’ for Diet Drug Acomplia Is Loss of Sanofi’s Huge Lead
As month after month passes with no sign of imminent FDA action on diet drug rimonabant (Acomplia / Zimulti) , the most significant “wait loss” taking place is loss of the hugh lead Sanofi-Aventis once had in developing a novel approach to weight-loss based on [...]
